Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 28, 2025
Medical Humidifier Market worth US$1,211.7 million by 2029 with 5.6% CAGR | MarketsandMarkets™.
GlobeNewswire
·
March 28, 2025
Delray Beach, FL, March 28, 2025 (GLOBE NEWSWIRE) -- The global Medical Humidifier Market, valued at US$878.4 million in 2023, is forecasted to grow at a robust CAGR of 5.6%, reaching US$922.8 million in 2024 and an impressive US$1,211.7 million by 2029. …
Coherent Announces General Availability of 800G ZR/ZR+ QSFP-DD Transceiver
GlobeNewswire
·
March 28, 2025
SAXONBURG, Pa., March 28, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announces general availability of its 800G ZR/ZR+ transceiver in QSFP-DD form factor. This launch reinforces the company’s commitment to next- …
NANO Nuclear Energy Bolsters the Engineering Team Overseeing the Development of its ODIN™ Microreactor with Three Additional Leading Professionals
GlobeNewswire
·
March 28, 2025
New York, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that three …
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
GlobeNewswire
·
March 28, 2025
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its participation as a gold …
Neurostimulation Devices Market Set to Reach US$ 11.83 Billion by 2030, Driven by Rising Neurological Disorders and Technological Advancements - The Insight Partners
GlobeNewswire
·
March 28, 2025
US …
Aptose Reports Year End 2024 Results and Corporate Highlights
GlobeNewswire
·
March 28, 2025
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to Include in AML Triplet Therapy Aptose Signs Debt Conversion Agreement with Hanmi SAN DIEGO and TORONTO, March 28, …
Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman
GlobeNewswire
·
March 28, 2025
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
GlobeNewswire
·
March 28, 2025
CB1 inverse agonism is a clinically validated mechanism to induce weight loss CRB-913 is markedly more peripherally restricted compared to monlunabant and rimonabant SAD/MAD Phase 1 trial scheduled for completion Q3 2025 and Phase 1b dose-range finding …
GlobalTech Corporation Announces Fourth Quarter and Year End 2024 Results
GlobeNewswire
·
March 28, 2025
RENO, Nev., March 28, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (GTC, OTC:GTLK) (“GlobalTech” or the “Company”), a leading U.S.-based technology investment holding company, today announced financial results for the year ending December 31, 2024. Full …
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
GlobeNewswire
·
March 28, 2025
Marlton, NJ, March 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it received European CE Mark approval for an expanded …
Actelis Receives Significant New Orders to Modernize U.S. Military Bases with Rapid Deployment, Cyber Hardened Networking
GlobeNewswire
·
March 28, 2025
FREMONT, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced it has …
Tide Capital Sees Bitcoin Entering Strategic Buy Zone Amid Macro Turbulence
GlobeNewswire
·
March 28, 2025
New York, NY, March 28, 2025 (GLOBE NEWSWIRE) -- Bitcoin’s recent price retreat has created a strategic entry point, according to Tide Capital, as recession risks and institutional dynamics signal a potential market bottom. Despite macroeconomic headwinds, …
Vicon’s new markerless system enabling Dreamscape Immersive’s latest VR experience
GlobeNewswire
·
March 28, 2025
28 March 2025 Oxford Metrics plc ("Oxford Metrics" or the “Group”) Vicon’s new markerless system enabling Dreamscape Immersive’s latest VR experience New location-based VR technology to launch at Dreamscape’s Geneva flagship store in partnership with Swiss …
Mining Remanufacturing Components Market Size Worth $5.94 Billion, Globally, by 2030 Growing at 4.4% CAGR | Exclusive Report by The Insight Partners
GlobeNewswire
·
March 28, 2025
US …
Cavli Wireless to Feature the CQS315 and CQS325 Smart IoT Modules at CAEV Expo 2025
GlobeNewswire
·
March 28, 2025
BENGALURU, India, March 28, 2025 (GLOBE NEWSWIRE) -- Cavli Wireless, a leader in the Cellular IoT Solutions space, is excited to announce the introduction of their flagship LTE Cat 4 Smart Module series, the CQS315 and CQS325, at the CAEV Expo 2025. This …
Horizontal Directional Drilling (HDD) Market Size worth $6.42 billion by 2030 With Growing at CAGR 10.9% - Exclusive Report by The Insight Partners
GlobeNewswire
·
March 28, 2025
US …
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
GlobeNewswire
·
March 28, 2025
THE WOODLANDS, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin development …
LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
GlobeNewswire
·
March 28, 2025
Focused on the evaluation of strategic alternatives Adopted a restructuring plan to extend capital resources, incurring a reduction in workforce of 30% to support the evaluation of strategic options and the Phase 1 study for LAVA-1266 Phase 1 enrollment in …
Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 28, 2025
- Received U.S. Food and Drug Administration (FDA) approval of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma - - Commenced market launch and first commercial sales of Symvess - - Budget Impact Model for …
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
GlobeNewswire
·
March 28, 2025
- Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor patient population - - Solnerstotug continues to demonstrate a well-tolerated safety and tolerability profile - - …